Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Researchers outline statewide study to map pharmacy access to oral and injectable PrEP and ask board for input
Summary
A University of California research team told the board it will survey a representative sample of California community pharmacies and pharmacists, use a mystery‑shopper design and discrete‑choice experiments, and interview pharmacists and PrEP users to identify implementation barriers to oral and long‑acting injectable PrEP.
A California research team presented plans on Feb. 6 to study how community pharmacies in the state can implement pre‑exposure prophylaxis (PrEP) for HIV — including the newer long‑acting injectable agents — and asked the California Board of Pharmacy for input and channels for dissemination.
Study design in brief The investigators described a two‑part, statewide approach: a mystery‑shopper (secret‑shopper) telephone survey of a representative sample of community pharmacies to measure whether pharmacist‑initiated PrEP services are available, and a second, longer individual survey of pharmacists, managers and owners from the sampled…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
